Schwab US Dividend Equity ETF vs Health Care Select Sector SPDR Fund — how do they compare? Schwab US Dividend Equity ETF trades at $34.26, while Health Care Select Sector SPDR Fund trades at $168.56. Which is the better fit depends on your goals.
| SCHD | XLV | |
|---|---|---|
Sector | Broad Market / Factor | — |
52-Week High | $34.27 | $168.44 |
52-Week Low | $26.44 | $131.16 |
Signals from Pluang's Aura AI — not financial advice
SCHD trades at $34.225, up 0.1% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The ETF's dividend strategy remains a core appeal, highlighted by a scheduled $0.25 dividend in June 2026. Recent news emphasizes its role in retirement income portfolios and institutional accumulation, such as Barry Investment Advisors increasing its stake by 29.9% in Q2 2026.
Outlook is supported by dividend reliability and value rotation trends, but risks include yield competition from Treasuries and tax inefficiencies in taxable accounts. The ETF suits income-focused investors seeking steady payouts, though overbought conditions may limit near-term gains.
XLV, the Health Care Select Sector SPDR ETF, trades at $167.93, down 0.3% on the day, with a bullish technical signal driven by moving averages. The ETF offers broad healthcare exposure with a low expense ratio of 0.08% and a trailing dividend yield of 1.6%, positioning it as a cost-effective defensive play amid market volatility. Recent news highlights strong sector inflows and defensive demand, with earnings from key holdings like UnitedHealth showing resilience despite Medicaid pressures.
The outlook for XLV is positive, supported by its defensive characteristics and institutional interest, though risks include regulatory pressures and sector-specific volatility. Investors may find value in its diversification and steady performance, but should monitor healthcare policy developments and earnings trends for sustained growth.
Trailing returns across standard periods
Latest headlines on both assets
SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →